← Back to Clinical Trials
Recruiting NCT07873541

NCT07873541 Comparison of Different Exercise Protocols for Diagnosed With Lipedema

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07873541
Status Recruiting
Phase —
Sponsor Hitit University
Condition Aerobic Exercise
Study Type INTERVENTIONAL
Enrollment 66 participants
Start Date 2026-09-11
Primary Completion 2027-09-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
High-Intensity Interval Aerobic Exercise GroupModerate Intensity Continuous Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 66 participants in total. It began in 2026-09-11 with a primary completion date of 2027-09-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study was designed to compare the effects of high-intensity interval training and moderate-intensity continuous training on functional capacity, muscle strength, and quality of life in patients with lipedema, and to determine the most effective exercise training protocol for this population.

Eligibility Criteria

Inclusion Criteria: * Aged 18-65 years and diagnosed with lipedema. * Have not participated in a structured exercise training program within the previous 3 months. * Voluntarily agree to participate in the study and provide informed consent. Exclusion Criteria: * Presence of cardiopulmonary, rheumatologic, or neurological conditions causing symptoms of sufficient severity to prevent participation in the exercise program. * History of cancer or presence of thyroid disorders. * Presence of edema primarily attributable to conditions other than lipedema, including lymphedema, venous edema, or edema secondary to heart or renal failure. * Body mass index (BMI) \> 50.0 kg/m².

Contact & Investigator

Central Contact

Ayla Cağlıyan Turk

✉ drayla1976@hotmail.com

📞 +095334314171

Frequently Asked Questions

Who can join the NCT07873541 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Aerobic Exercise. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07873541 currently recruiting?

Yes, NCT07873541 is actively recruiting participants. Contact the research team at drayla1976@hotmail.com for enrollment information.

Where is the NCT07873541 trial being conducted?

This trial is being conducted at Çorum, Turkey (Türkiye).

Who is sponsoring the NCT07873541 clinical trial?

NCT07873541 is sponsored by Hitit University. The trial plans to enroll 66 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology